0.703
0.0018 (0.26%)
0.0018 (0.26%)
Upgrade to Real-Time
Regular Market
Low
0.4222
High
2.32
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0018 | 0.26% | 0.703 | 13:03:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7012 | 0.701 | 0.7252 | 0.7012 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.7029 | 0.706 | 0.0031 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 522 | 208,031 | $ 0.7057341 | $ 146,815 | - | 0.4222 - 2.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:03:27 | 100 | $ 0.703 | USD |
Period:
Draw Mode:
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 52.69M | 74.92M | 60.93M | $ 10.01M | $ -7.99M | -0.50 | -2.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 74.25k | 4.70% |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.70 | 0.79 | 0.685 | 0.7262891 | 727,400 | 0.003 | 0.43% |
| 1 Month | 0.882 | 0.8889 | 0.685 | 0.7806918 | 1,443,370 | -0.179 | -20.29% |
| 3 Months | 1.36 | 1.48 | 0.685 | 0.9878938 | 3,501,960 | -0.657 | -48.31% |
| 6 Months | 1.26 | 2.32 | 0.685 | 1.34 | 3,247,738 | -0.557 | -44.21% |
| 1 Year | 0.831 | 2.32 | 0.4222 | 1.20 | 2,395,466 | -0.128 | -15.4% |
| 3 Years | 3.60 | 4.068 | 0.4005 | 1.28 | 1,179,328 | -2.90 | -80.47% |
| 5 Years | 41.64 | 51.00 | 0.4005 | 5.56 | 980,424 | -40.94 | -98.31% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
